9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice

Clinical Cancer Research

Volumn 6, Issue 9, 2000, Pages 3696-3704

  Wu, K ^a   Kim, H T ^a   Rodriquez, J L ^a   Munoz Medellin, D ^a   Mohsin, S K ^a   Hilsenbeck, S G ^a   Lamph, W W ^a   Gottardis, M M ^a   Shirley, M A ^a   Kuhn, J G ^a   Green, J E ^a   Brown, P H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CHEMOTHERAPY; DRUG EFFECT; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; TRETINOIN;

EID: 0033813160     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
2. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results form the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation
3. Cellular biology and biochemistry of the retinoids
4. Cellular biology and biochemistry of the retinoids
5. The steroid and thyroid hormone receptor superfamily
6. Retinoids, retinoid-response genes, cell differentiation and cancer
7. Induction of retinoid resistance in breast cancer cells by overexpression of c-Jun
8. All-trans, 13-cis, and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: Implications for in vivo retinoic acid use
9. Effects of novel retinoid x receptor-selective ligands on myeloid leukemic differentiation and proliferation in vitro
10. 9-cis Retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein
11. The efficacy of 9-cis retinoic acid in experimental models of cancer
12. Effects of novel retinoic acid compound, 9-cis retinoic acid, on proliferation, differentiation, an expression of retinoic acid receptor-α and retinoid X receptor-α RNA by HL-60 cells
13. A novel retinoic acid receptor (RAR)-selective antagonist inhibits differentiation and apoptosis of HL-60 cells: Implications of RARa-mediated signals in myeloid leukemic cells
14. Activation of retinoid x receptors induces apoptosis in HL-60 cell lines
15. Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells
16. Current approaches to acute promyelocytic leukemia
17. Therapy of acute promyelocytic leukemia: All-trans retinoic acid and beyond
18. 13-cis-retinoic acid and interferon α-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin
19. 13-cis-Retinoic acid plus interferon α-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix
20. Combination 13-cis-retinoic acid and interferon α-2a in the therapy of solid tumors
21. Retinoids and carotenoids
22. Cancer chemoprevention
23. Biologic basis of retinoid pharmacology: Implications for cancer prevention and therapy
24. A Phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy
25. Prevention of second primary tumors with isotretinoin in squamous carcinoma of the head and neck
26. Adjuvant treatment of stage I lung cancer with high dose vitamin A
27. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma
28. Animal models of breast cancer: Experimental design and their use in nutrition and psychosocial research
29. Expression of activated oncogenes in the murine mammary gland: Transgenic models for human breast cancer
30. Transgenic mouse models of breast cancer
31. Experimentally induced mammary tumors in rats
32. Dietary retinoids and carotenoids in rodent models of mammary tumorigenesis
33. Inhibition of carcinogenesis by retinoids
34. Inhibition of 7,12 dimethylbenz(a)anthracene-induced mammary carcinogenesis by retinyl acetate
35. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): An RXR-selective ligand
36. Beyond tamoxifen: The retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma
37. Prevention of breast cancer in the rat with 9-cis retinoic acid as a single agent and in combination with tamoxifen
38. Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer
39. The C3(1)/SV40 T-antigen transgenic mouse model of mamary cancer: Ductal epithelial cell targeting with multistage progression to carcinoma
40. Molecular genetics of human breast cancer
41. Activated oncogenes and putative tumor suppressor genes involved in human breast cancers
42. Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid
43. Phase I trial of 9-cis retinoic acid in adults with solid tumors
44. All-trans-retinoic acid inhibits Jun N-terminal kinase-dependent signaling pathways
45. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation
46. Induction of retinoid resistance in breast cancer cells by overexpression of c-Jun
47. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model
48. The p53 tumor suppressor gene in breast cancer
49. Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions
50. Mutant p53: Gain-of-function oncoproteins and wildtype p53 inactivators
51. All-trans retinoic acid induced differentiation of rat mammary epithelial cells cultured in serum-free medium
52. Modulation of mammary carcinoma cell phenotype and keratin expression patterns by retinoic acid
53. Effect of early vs. late administration of 4-hydroxyphenylretinamide (4-HPR) on N-methyl-N-nitrosourea (MNU)-induced mammary tumorigenesis
54. Chemoprevention of cancer